ATE212844T1 - Medikament gegen myotonische dystrophie - Google Patents

Medikament gegen myotonische dystrophie

Info

Publication number
ATE212844T1
ATE212844T1 AT95927977T AT95927977T ATE212844T1 AT E212844 T1 ATE212844 T1 AT E212844T1 AT 95927977 T AT95927977 T AT 95927977T AT 95927977 T AT95927977 T AT 95927977T AT E212844 T1 ATE212844 T1 AT E212844T1
Authority
AT
Austria
Prior art keywords
myotonic dystrophy
medicine
adynamia
amyotrophy
myotonia
Prior art date
Application number
AT95927977T
Other languages
English (en)
Inventor
Nakaaki Ohsawa
Maskazu Sugino
Tomio Endo
Original Assignee
Nakaaki Ohsawa
Maskazu Sugino
Tomio Endo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nakaaki Ohsawa, Maskazu Sugino, Tomio Endo filed Critical Nakaaki Ohsawa
Application granted granted Critical
Publication of ATE212844T1 publication Critical patent/ATE212844T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Excavating Of Shafts Or Tunnels (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT95927977T 1994-08-08 1995-08-07 Medikament gegen myotonische dystrophie ATE212844T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6205939A JP2698865B2 (ja) 1994-08-08 1994-08-08 筋緊張性ジストロフィー症治療剤
PCT/JP1995/001561 WO1996004917A1 (fr) 1994-08-08 1995-08-07 Remede contre la myotonie atrophique

Publications (1)

Publication Number Publication Date
ATE212844T1 true ATE212844T1 (de) 2002-02-15

Family

ID=16515230

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95927977T ATE212844T1 (de) 1994-08-08 1995-08-07 Medikament gegen myotonische dystrophie

Country Status (6)

Country Link
US (1) US5834451A (de)
EP (1) EP0776663B1 (de)
JP (1) JP2698865B2 (de)
AT (1) ATE212844T1 (de)
DE (1) DE69525348T2 (de)
WO (1) WO1996004917A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2803519B1 (fr) * 2000-01-12 2002-03-22 Assist Publ Hopitaux De Paris Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs et de ses derives pour ameliorer l'aspect papyrace de la peau
ES2553101T3 (es) 2004-10-20 2015-12-04 Endorecherche Inc. Precursor de esteroides sexuales en combinación con un modulador selectivo del receptor de estrógenos para la prevención y tratamiento de atrofia vaginal en mujeres postmenopáusicas
US8268806B2 (en) * 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
CA2639412A1 (en) 2007-09-11 2009-03-11 Universite Laval Prostaglandin e2 modulation and uses thereof
US8754084B2 (en) 2012-03-27 2014-06-17 The Board Of Trustees Of The University Of Illinois Therapeutic methods and agents for treating myotonic dystrophy
CA2956464C (en) 2014-08-08 2023-05-09 The Board Of Trustees Of The University Of Illinois Bisamidinium-based inhibitors for the treatment of myotonic dystrophy
US11242326B2 (en) 2017-08-25 2022-02-08 The Board Of Trustees Of The University Of Illinois Multivalent ligand for myotonic dystrophy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005200A (en) * 1975-07-17 1977-01-25 Kanebo, Ltd. Method for improving the maturity of the parturient canal and the sensitivity to oxytocin
CA1254514A (en) * 1984-06-29 1989-05-23 Eugene Roberts Method for promoting nerve regeneration
JPS63267722A (ja) * 1987-04-27 1988-11-04 Daiichi Yakuhin Sangyo Kk 抗肥満症剤
JP3280726B2 (ja) * 1992-12-18 2002-05-13 日本オルガノン株式会社 抗潰瘍剤

Also Published As

Publication number Publication date
DE69525348D1 (de) 2002-03-21
EP0776663A1 (de) 1997-06-04
JP2698865B2 (ja) 1998-01-19
DE69525348T2 (de) 2002-09-26
US5834451A (en) 1998-11-10
EP0776663A4 (de) 1997-10-29
JPH0848630A (ja) 1996-02-20
EP0776663B1 (de) 2002-02-06
WO1996004917A1 (fr) 1996-02-22

Similar Documents

Publication Publication Date Title
RS50485B (sr) Terapeutske kombinacije koje sadrže amplodipin i atorvastatin
DE10399022I1 (de) Androstenderivate.
ID28003A (id) Turunan-turunan adamantana
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
DE69410716D1 (de) Aufreissbare Luftsackrückhalteklappe
DE69521672D1 (de) Topisch verabreichbare zinkphthalocyaninhaltige Mittel
NO307459B1 (no) Piperazinderivater, samt farmasøytiske preparater inneholdende slike
ITRM910696A1 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
NO953454D0 (no) Lukkeanordning for medikamentbeholder
AU6379294A (en) Nasal pharmaceutical composition containing a progestational agent
DE69403660D1 (de) Verschlussklappen-faltmaschine
DE69131714D1 (de) Cephalosporine und ihre homologen, zubereitungen und pharmazeutsiche präparate
DK0853617T3 (da) 2,3-Dioxo-1,2,3,4-tetrahydro-quinoxalinylderivater
TR199900651T2 (xx) Kaplanm�� par�ac�k form�lasyonu.
ZA965712B (en) New oxazolidinone derivatives, processes for the production thereof and pharmaceutical agents containing these compounds.
ATE212844T1 (de) Medikament gegen myotonische dystrophie
NO179586C (no) 4,13-dioksabisyklo[8.2.1Åtridecenonderivater og legemidler inneholdene disse forbindelser
DE69512715D1 (de) Aconitin ähnliche verbindung und antipyretisches, analgetisches und entzündungshemmendes mittel
ES2126155T3 (es) Nuevos compuestos aminoesteroidales que contienen uretano.
EE04347B1 (et) 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, neid sisaldav ravim ja farmatseutiline kompositsioon
EP0646568A3 (de) Tertiärbutylesterderivate der 4,4-bis (4'Hydroxyphenyl)pentansäure und diese enthaltende positive Photoresiste.
FR2705569B1 (fr) Composition pharmaceutique à base d'une imidazolylcarbazolone destinée à l'administration rectale.
Font et al. Finding the words: Instruments for a therapy of liberation
DE59309355D1 (de) Neue Phospholipidderivate
FR2698544B1 (fr) Composition pharmaceutique topique pour allergies respiratoires.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties